Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.

Marthey, L

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease. [electronic resource] - Journal of Crohn's & colitis Apr 2016 - 395-401 p. digital

Publication Type: Journal Article

1876-4479

10.1093/ecco-jcc/jjv227 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
CTLA-4 Antigen--immunology
Colectomy
Colon--pathology
Enterocolitis--chemically induced
Female
Humans
Immunotherapy--adverse effects
Inflammatory Bowel Diseases--chemically induced
Ipilimumab
Male
Melanoma--therapy
Middle Aged
Young Adult